Due to many requests, INSTAND e.V. introduces a new External Quality Assessment (EQA) scheme for the "Virus Genome Detection Monkeypox Virus" (418).
This EQA scheme is performed in cooperation with the National Consultant Laboratory for Poxviruses, Robert Koch Institute, Centre for Biological Threats and Special Pathogens, ZBS 1 Highly Pathogenic Viruses, Berlin, and in agreement with the Joint Diagnostic Council of Deutsche Vereinigung zur Bekaempfung der Viruskrankheiten (DVV e.V.) and Gesellschaft fuer Virologie (GfV e.V.).
Details of this new EQA scheme are as follows:
Number of samples and sample properties:
1 set = 4 samples à 1,1 ml each, lyophilized cell culture supernatants
Monkeypox virus-positive samples were inactivated
Monkeypox virus (DNA) - qualitative Orthopoxvirus (DNA) - qualitative
Monkeypox virus (DNA) - quantitative Orthopoxvirus (DNA) - quantitative
|For Germany and EU countries||For non EU-countries|
|Registration and deregistration period||07.09.2022||24.08.2022|
|Shipment of Samples||21.09.2022|
|Deadline of result entry||07.10.2022|
Additional dates will be posted on the INSTAND homepage as needed.
Note for laboratories from non-EU countries (application deadline 24.08.2022):
The shipment of sample materials for participation in this EQA scheme is subject to a release by the Federal Office of Economics and Export Control according to the EU Dual-Use Regulation (VO (EU) 2021/821) for sample recipients in non-EU states. INSTAND e.V. can only process EQA scheme orders from non-EU countries if the ordering laboratories provide a completed end-user declaration, a company profile including contact details (e.g., excerpt from website), and, if applicable, an import permit! Incomplete data will, unfortunately, lead to a cancellation of your registration.
320,- € / survey
For registration, please visit https://rv-online.instandev.de/index.shtml?lang=en and register in the EQAS Online system for placing your order(s).